{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-090746","form_type":"8-K","ticker":"AIDX","cik":"0001139685","company_name":"20/20 Biolabs, Inc.","filed_at":"2026-08-17T20:05:37+00:00","discovered_at":"2026-08-17T20:07:01.348768+00:00","generated_at":"2026-08-17T20:09:08.621457+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"20/20 BioLabs Q2 revenue up 37% to $0.7M; OneTest revenue up 47%","bullets":["Q2 2026 total revenue $0.7M, up 36.5% YoY; OneTest revenue $0.7M, up 47.1%, 95.3% of total.","Gross profit $0.3M, up 86.6%; gross margin 41.7% vs 30.5%.","Net loss $1.5M vs $0.8M; cash $4.5M, up from $1.0M; convertible note debt eliminated.","Vermont and Maryland firefighter programs expected to generate >$1.0M revenue through 2026; >35,000 firefighters tested by year-end.","Raised $6.0M Series E preferred in H1 2026; up to $40M available; standstill with Streeterville."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-090746","json":"https://secwatch.observer/filing/0001213900-26-090746.json","markdown":"https://secwatch.observer/filing/0001213900-26-090746.md","text":"https://secwatch.observer/filing/0001213900-26-090746.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1139685/000121390026090746/0001213900-26-090746-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1139685/000121390026090746/ea0302153-8k_2020bio.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-17T20:09:08.621457+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}